James Howard-Tripp
Vorstandsvorsitzender bei STAGEZERO LIFE SCIENCES LTD.
Vermögen: 6 052 $ am 30.04.2024
Aktive Positionen von James Howard-Tripp
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
STAGEZERO LIFE SCIENCES LTD. | Vorsitzender | 19.07.2013 | - |
Vorstandsvorsitzender | 10.08.2016 | - | |
Public Communications Contact | 01.01.2002 | - | |
Direktor/Vorstandsmitglied | 01.01.2002 | 19.07.2013 | |
Independent Dir/Board Member | 01.01.2002 | 19.07.2013 | |
Canadian Healthcare Licensing Association | Corporate Officer/Principal | 20.08.2009 | - |
Vorsitzender | - | 20.08.2009 | |
Innovative Diagnostic Laboratory LLP
Innovative Diagnostic Laboratory LLP Medical/Nursing ServicesHealth Services Innovative Diagnostic Laboratory LLP offers risk assessment blood tests to find, understand, and treat cancer for the prevalent cancer types. Its products include colonsentry, earlyCDT-Lung, and prostate health index. The company is headquartered in Richmond, VA. | Vorstandsvorsitzender | - | - |
GeneNews (USA), Inc.
GeneNews (USA), Inc. Medical SpecialtiesHealth Technology GeneNews (USA), Inc. operates as a cancer diagnostics company. The firm focuses on developing and commercializing proprietary molecular diagnostic tests for the early detection of diseases and personalized health management, with a primary focus on cancer-related indications. The company was incorporated on August 20, 2013 and is headquartered in Glen Allen, VA. | Direktor/Vorstandsmitglied | - | - |
Präsident | - | - |
Karriereverlauf von James Howard-Tripp
Ehemalige bekannte Positionen von James Howard-Tripp
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Labopharm, Inc.
Labopharm, Inc. BiotechnologyHealth Technology Labopharm, Inc. discovers and develops drugs. The company was founded in 1990 and is headquartered in Montreal, Canada. | Direktor/Vorstandsmitglied | 22.12.2010 | 14.03.2011 |
Vorstandsvorsitzender | 01.01.1999 | 14.03.2011 | |
Präsident | 01.01.1999 | 14.03.2011 | |
Allelix Biopharmaceuticals, Inc. | Geschäftsführer | 01.01.1996 | - |
Wyeth Ayerst Canada, Inc. | Corporate Officer/Principal | - | - |
Allelix Neuroscience, Inc. | Präsident | - | - |
Paladin Labs Europe Ltd. | Präsident | - | - |
Statistik
International
Kanada | 6 |
Vereinigte Staaten | 4 |
Irland | 2 |
Operativ
President | 4 |
Director/Board Member | 3 |
Chief Executive Officer | 3 |
Sektoral
Health Technology | 5 |
Health Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
STAGEZERO LIFE SCIENCES LTD. | Health Technology |
Private Unternehmen | 8 |
---|---|
Labopharm, Inc.
Labopharm, Inc. BiotechnologyHealth Technology Labopharm, Inc. discovers and develops drugs. The company was founded in 1990 and is headquartered in Montreal, Canada. | Health Technology |
Canadian Healthcare Licensing Association | |
Paladin Labs Europe Ltd. | |
Allelix Biopharmaceuticals, Inc. | Health Technology |
Allelix Neuroscience, Inc. | |
Wyeth Ayerst Canada, Inc. | |
Innovative Diagnostic Laboratory LLP
Innovative Diagnostic Laboratory LLP Medical/Nursing ServicesHealth Services Innovative Diagnostic Laboratory LLP offers risk assessment blood tests to find, understand, and treat cancer for the prevalent cancer types. Its products include colonsentry, earlyCDT-Lung, and prostate health index. The company is headquartered in Richmond, VA. | Health Services |
GeneNews (USA), Inc.
GeneNews (USA), Inc. Medical SpecialtiesHealth Technology GeneNews (USA), Inc. operates as a cancer diagnostics company. The firm focuses on developing and commercializing proprietary molecular diagnostic tests for the early detection of diseases and personalized health management, with a primary focus on cancer-related indications. The company was incorporated on August 20, 2013 and is headquartered in Glen Allen, VA. | Health Technology |
- Börse
- Insiders
- James Howard-Tripp
- Erfahrung